The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Re: Recurrences with brain mets from BRAF/MEK Drugs?

Forums General Melanoma Community Recurrences with brain mets from BRAF/MEK Drugs? Re: Recurrences with brain mets from BRAF/MEK Drugs?

    Carver
    Participant

      That’s an interesting question but I have to say that from my participation on the MPIP for five years I have seen a number of patients who responded to a variety of treatments recur with brain mets so I think with the newer treatments it would be hard to to tell if that is particularly true of them. I know that several patients who I got to know had some response to IL2 and then recurred to the brain. Of course fortunately many others have had long term remision from that and other treatments.

      I also think that in terms of BRAF and MEF inhibitor drugs it would be necessary to get larger results from trials than are currently available for it to be analyzed with any hope of results of value.

      Something that has come up a lot on the MPIP is that it’s hard to take the population of participants here and draw conclusions. That can be an issue when lower stage patients see a lot of recurrences among lower stage patients that post here. In that case it’s self selecting because most lower stage patients don’t generally have as much of a need to participate on a board like this one, therefore, many people that do stick around do so because they have recurred where those without recurrences are no longer active participants.

      The new trials are a separate issue but I still think it would be hard to see if stage IV patients doing one trial are more likely to have brain mets that those in another treatment without some kind of controlled trial  looing into this issue.

      That’s just my opinion of course and I am a stage III patient who hasn’t done the treatment in question.

    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.